Improving formulary compliance with managed care members

Drug Benefit Trends

Volumn 14, Issue 7, 2002, Pages 44-46

  Nair, Kavita V ^a   Ganther, Julie M ^a   Valuck, Robert J ^a   McCollum, Marianne ^a   Lewis, Sonya J ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CELECOXIB; DICLOFENAC; FLUINDOSTATIN; FOSINOPRIL; GENERIC DRUG; HYDROCHLOROTHIAZIDE PLUS LISINOPRIL; HYDROCHLOROTHIAZIDE PLUS LOSARTAN; LISINOPRIL; LOSARTAN POTASSIUM; NABUMETONE; PRAVASTATIN; QUINAPRIL; ROFECOXIB; SIMVASTATIN; VALSARTAN;

ARTHRITIS; CHRONIC DISEASE; COMPETENCE; CONSUMER; COST EFFECTIVENESS ANALYSIS; DOCTOR PATIENT RELATION; DRUG CHOICE; DRUG COST; DRUG FORMULARY; DRUG INFORMATION; DRUG WITHDRAWAL; DYSLIPIDEMIA; HEALTH CARE ACCESS; HEALTH CARE POLICY; HEALTH INSURANCE; HEALTH STATUS; HUMAN; HYPERTENSION; INTERPERSONAL COMMUNICATION; MANAGED CARE; MANAGED CARE ORGANIZATION; MEDICAL DECISION MAKING; PATIENT CARE; PATIENT COMPLIANCE; PHARMACIST; PHYSICIAN; PRESCRIPTION; QUESTIONNAIRE; SHORT SURVEY; SOCIOECONOMICS;

EID: 0036348173     PISSN: 10805826     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (3)

1. On the evaluation of drug benefits policy changes with longitudinal claims data: The policy maker's versus the clinician's perspective
2. Can patient demand for pharmaceuticals be moderated?
3. Community pharmacist knowledge and behavior in collecting drug copayments from Medicaid recipients